|
| View:
Latest News | Top Stories |
|
| 1.
|
Helicos and Mass General Hospital Publish Epigenomic Study in Nature Methods
-
Business Wire
-
Tue 7:30 am ET
CAMBRIDGE, Mass.----Helicos BioSciences Corporation today announced the publication of a landmark study by Dr. Bradley Bernstein of the Massachusetts General Hospital describing the use of Helicos’ single molecule sequencing technology for the performance of genome-wide, epigenomic experiments using minute amounts of nucleic acid.
|
|
| 2.
|
Par Pharma buys back $30.8M in senior notes
-
AP
-
Wed Nov 25
Par Pharmaceuticals Cos. said Wednesday it bought $30.8 million in senior notes through a tender offer. Earlier this month, the company had offered to buy back up to $65 million in convertible senior notes due 2010.
|
|
| 3.
|
Drugmaker Par Shapes A Base But Needs Time
-
Investor's Business Daily
-
Fri Nov 20
Generic and branded drugmaker Par Pharmaceutical notched a 52-week high in mid-October.
|
|
| 4.
|
Mylan's President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
-
PR Newswire
-
Wed Nov 18
Mylan Inc. today announced that Didier Barret, president of Mylan Europe, Middle East and Africa , has been elected president of the European Generic Medicines Association . Barret was elected to a two-year term earlier today at the EGA annual meeting being held in Brussels.
|
|
| 5.
|
Cannabis Science Hails The American Medical Association For Urging The United States To Facilitate Clinical Research and Development of Cannabinoid-Based Medicines...
-
Business Wire
-
Mon Nov 16
COLORADO SPRINGS, Colo.---- Cannabis Science Hails The American Medical Association For Urging The United States To Facilitate Clinical Research and Development of Cannabinoid-Based Medicines Which Validates The Company’s Strategy To Produce Critically Important FDA Approved Cannabinoid-Based Medicines For Patients
|
|
| 6.
|
Hi-Tech Pharmacal's ECR Subsidiary Signs Exclusive Agreement to Commercialize Sleep Aid in Oral Spray Form
-
Business Wire
-
Mon Nov 16
AMITYVILLE, N.Y.----Hi-Tech Pharmacal Co., Inc. announced today the signing of an exclusive licensing agreement between Hi-Tech’s ECR Pharmaceuticals subsidiary and NovaDel Pharma, Inc., a drug development company, through which ECR obtained the rights to market zolpidem tartrate oral spray, 5mg per spray, in the United States and Canada.
|
|
| 7.
|
Catalyst Receives Guidance from Nasdaq Regarding Minimum Bid Price Requirement
-
PR Newswire
-
Fri Nov 13
Catalyst Pharmaceutical Partners, Inc. announced today that it received a Nasdaq Staff Deficiency Letter dated November 13, 2009 indicating that the Company is not in compliance with the Minimum Bid Price requirement set forth in Nasdaq Listing Rule 5550 for continued listing on the Nasdaq Capital Market.
|
|
| 8.
|
Pro-Pharmaceuticals Reports Third Quarter Financial Results
-
Business Wire
-
Fri Nov 13
NEWTON, Mass.----Pro-Pharmaceuticals, Inc. , a developer of galectin-targeted, carbohydrate therapeutic compounds to treat cancer and fibrosis, today reported its financial results for the third quarter and first nine months of fiscal 2009.
|
|
| 9.
|
Helicos no longer considering sale
-
AP
-
Tue Nov 10
Helicos BioSciences Corp. has taken itself off the auction block, the genetic analysis instrument company said Monday. In September, the company said it hired Thomas Weisel Partners to evaluate strategic alternatives.
|
|
| 10.
|
In Anticipation Of Medical Marijuana Legalization, Cannabis Science Adds Four Attorneys To Its New Policy Advisory Board, All Are Experts In the Development Of Medical Marijuana Laws
-
Business Wire
-
Wed Oct 21
COLORADO SPRINGS, Colo.----Cannabis Science Inc. an emerging pharmaceutical cannabis company is very pleased to announce that has added four prominent attorneys, who specialized in marijuana-related cases, to its Policy Advisory Board, as medical marijuana legalization moves closer with President Obama’s New Medical Marijuana Policies and initiatives.
|
|
